A pooled analysis of 5 studies revealed a significant decrease in the level of TGF-β in SLE patients compared to controls (SMD=-0.92; 95%CI=-1.48, -0.36; p=0.001; n=5; Figure 10). Here, TGFB1 is linked to systemic lupus erythematosus.